Travel prophylaxis

BMJ 1995; 310 doi: https://doi.org/10.1136/bmj.310.6976.401c (Published 11 February 1995) Cite this as: BMJ 1995;310:401

Figures in study were incorrect

  1. E Walker*
  1. Director Travel Advisory Service, Scottish Centre for Infection and Environmental Health, Ruchill Hospital, Glasgow G20 9NB

    EDITOR,—Debate about the role of immunoprophylaxis for travellers is to be encouraged, but health care planners should not be lulled into complacency by R H Behrens and J A Roberts's conclusion that vaccination against typhoid and hepatitis A is not cost effective for society or the person concerned.1 No such study should group all countries outside Europe, North America, and Australasia into the same category of risk regardless of the …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription